Terms: = Breast cancer AND PTK6, BRK, 5753, ENSG00000101213, Q13882, FLJ42088 AND Diagnosis
3 results:
1. Comprehensive Analysis Reveals ptk6 as a Prognostic Biomarker Involved in the Immunosuppressive Microenvironment in breast cancer.
Wang L; Luo S; Wang Z; Huang Y; Luo Y; Xie X
J Immunol Res; 2022; 2022():5160705. PubMed ID: 36405012
[TBL] [Abstract] [Full Text] [Related]
2. Descriptive characteristics of prostate cancer in patients with a history of primary male breast cancer - a SEER analysis.
Abhyankar N; Hoskins KF; Abern MR; Calip GS
BMC Cancer; 2017 Sep; 17(1):659. PubMed ID: 28946846
[TBL] [Abstract] [Full Text] [Related]
3. Additive impact of HER2-/ptk6-RNAi on interactions with HER3 or IGF-1R leads to reduced breast cancer progression in vivo.
Falkenberg N; Anastasov N; Höfig I; Bashkueva K; Lindner K; Höfler H; Rosemann M; Aubele M
Mol Oncol; 2015 Jan; 9(1):282-94. PubMed ID: 25241146
[TBL] [Abstract] [Full Text] [Related]
